Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.sunpharma.com | |
Market Cap | 360,919.96 Cr. | |
Enterprise Value(EV) | 359,096.77 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 37.12 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 40.52 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.74 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 260.05 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 5.78 | Calculated using Price: 1,504.25 |
Dividend Yield | 0.76 | Period Ending 2023-03 |
No. of Shares Subscribed | 239.93 Cr. | 2,399,334,970 Shares |
FaceValue | 1 | |
About Sun Pharmaceutical Industries Ltd. | ||
The company is among the largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business and a skilled team enables it to deliver high-quality products, trusted by customers and patients in many countries across the world, at affordable prices. |
1 Day |
|
-0.89% |
1 Week |
|
-0.65% |
1 Month |
|
-6.36% |
3 Month |
|
+10.10% |
6 Month |
|
+34.48% |
1 Year |
|
+54.92% |
2 Year |
|
+67.39% |
5 Year |
|
+226.80% |
10 Year |
|
+142.21% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 24.89 | 19.32 | 22.51 | 6.85 | 8.05 | 9.66 | 4.98 | 7.21 | 16.46 | |
Return on Capital Employed (%) | 25.06 | 18.64 | 21.48 | 8.4 | 8.68 | 10.07 | 5.66 | 9.28 | 17.24 | |
Return on Assets (%) | 14.6 | 11.39 | 14.08 | 4.24 | 5.17 | 6.58 | 3.54 | 5.2 | 11.85 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 25,638 | 32,982 | 36,640 | 38,314 | 41,409 | 45,264 | 46,463 | 48,011 | 55,995 | 59,826 | |
Non Curr. Liab. | 2,335 | 2,170 | 600 | 46 | 77 | 246 | -1,515 | -1,316 | -1,643 | -1,971 | |
Curr. Liab. | 16,147 | 13,144 | 17,887 | 19,864 | 17,340 | 15,706 | 16,146 | 17,208 | 19,906 | 15,023 | |
Minority Int. | 2,851 | 4,085 | 3,791 | 3,884 | 3,314 | 3,860 | 3,017 | 3,055 | 3,320 | 3,371 | |
Equity & Liab. | 46,972 | 52,381 | 58,917 | 62,109 | 62,139 | 65,077 | 64,110 | 66,958 | 77,579 | 76,249 | |
Non Curr. Assets | 18,056 | 22,440 | 25,964 | 30,473 | 31,070 | 33,423 | 33,668 | 32,094 | 37,696 | 36,896 | |
Curr. Assets | 28,916 | 29,934 | 32,947 | 31,636 | 31,069 | 31,654 | 30,442 | 34,865 | 39,862 | 39,354 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 46,972 | 52,381 | 58,917 | 62,109 | 62,139 | 65,077 | 64,110 | 66,958 | 77,579 | 76,249 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 27,392 | 28,109 | 31,308 | 26,416 | 29,066 | 32,838 | 33,498 | 38,654 | 43,886 | 47,445 | |
Other Income | 566 | 658 | 1,030 | 912 | 1,059 | 652 | 859 | 1,437 | 820 | 1,248 | |
Total Income | 27,958 | 28,767 | 32,338 | 27,328 | 30,125 | 33,489 | 34,357 | 40,092 | 44,706 | 48,693 | |
Total Expenditure | -19,543 | -19,950 | -21,626 | -20,881 | -22,792 | -25,863 | -25,030 | -28,773 | -32,424 | -34,781 | |
PBIDT | 8,414 | 8,817 | 10,712 | 6,447 | 7,333 | 7,626 | 9,327 | 11,319 | 12,281 | 13,912 | |
Interest | -579 | -523 | -400 | -518 | -555 | -303 | -141 | -127 | -172 | -258 | |
Depreciation | -1,195 | -1,038 | -1,265 | -1,500 | -1,753 | -2,053 | -2,080 | -2,144 | -2,529 | -2,578 | |
Taxation | -915 | -914 | -1,212 | -911 | -601 | -823 | -515 | -1,076 | -848 | -1,513 | |
Exceptional Items | -238 | -685 | -951 | -1,214 | -261 | -4,306 | -4,567 | -171 | -564 | ||
PAT | 5,488 | 5,657 | 7,836 | 2,568 | 3,209 | 4,187 | 2,285 | 3,406 | 8,561 | 8,999 | |
Minority Interest | -936 | -1,113 | -882 | -447 | -542 | -407 | 631 | -117 | -39 | -28 | |
Share Associate | -13 | 1 | 10 | -25 | -1 | -15 | -12 | -17 | -48 | -64 | |
Other Related Items | |||||||||||
Consolidated Net Profit | 4,539 | 4,546 | 6,964 | 2,096 | 2,665 | 3,765 | 2,904 | 3,273 | 8,474 | 8,906 | |
Adjusted EPS | 22 | 19 | 29 | 9 | 11 | 16 | 12 | 14 | 35 | 37 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 3,959 | 5,616 | 6,686 | 7,082 | 3,907 | 2,196 | 6,555 | 6,170 | 8,985 | 4,959 | |
Cash Fr. Inv. | -2,367 | -2,866 | -4,372 | -4,222 | -3,371 | -681 | -2,589 | 536 | -5,725 | -7,944 | |
Cash Fr. Finan. | 507 | -1,187 | -1,889 | -2,285 | -1,539 | -2,731 | -5,715 | -5,980 | -5,193 | 2,376 | |
Net Change | 2,099 | 1,563 | 426 | 575 | -1,003 | -1,215 | -1,749 | 726 | -1,934 | -608 | |
Cash & Cash Eqvt | 4,359 | 7,286 | 8,032 | 8,642 | 7,906 | 7,062 | 5,677 | 6,273 | 4,508 | 4,624 |
Tue, 23 Apr 2024
Loss/Duplicate-Share Certificate-XBRL Sun Pharmaceutical Industries Limited has informed the Exchange about Loss of share certificates |
Tue, 23 Apr 2024
Loss of Share Certificates Sun Pharmaceutical Industries Limited has informed the Exchange about Loss of Share Certificates |
Fri, 19 Apr 2024
Updates Sun Pharmaceutical Industries Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Order'. |
Thu, 25 Apr 2024 |
Closing Above Previous High |
Close Within 52 Week High Zone |
High Decrease in 1 Month |
High Increase in 3 Months |
High Increase in 6 Months |